Home › Trial NCT05110807
A Clinical Study to Evaluate the Tolerability and Pharmacokinetics of TQB3617 Capsule in Patients With Advanced Malignant Tumors
- Trial IDNCT05110807
- StatusUnknown
- PhasePhase 1
- Study typeInterventional
- SponsorChia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Enrollment38
- Start date2022-01-05
- ConditionsAdvanced Malignant Tumors
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.